NCT00094120View on ClinicalTrials.gov

"MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With Wet Age-Related Macular Degeneration (AMD)"

PHASE2TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Macular Degeneration
Interventions
DRUG

MSI-1256F (Squalamine Lactate)

Trial Locations (1)

19462

Genaera Corporation, Plymouth Meeting

Sponsors
All Listed Sponsors
lead

Genaera Corporation

INDUSTRY